Inhibition of ADORA3 Accelerates Hematoma Resolution and Neurological Recovery after ICH
Cerebrovascular Diseases · 2025
DOI: 10.1159/000549241 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cerebrovascular Diseases, 2025. Verfasst von Qi Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Microglia, Hematoma, Cerebral Hemorrhage, Receptor, Adenosine A3. Die Arbeit nennt 50 Literaturangaben.
Abstract (Originalsprache)
Introduction
Intracerebral hemorrhage (ICH) seriously threatens human health with a high mortality and disability rate. Promoting the microglia-mediated endogenous removal of hematoma can effectively reduce brain tissue damage. Adenosine 3 receptor (ADORA3) has been shown to participate in microglial phagocytosis; however, its role in ICH remains unclear. This study was performed to explore the potential role of ADORA3 and related mechanism in endogenous hematoma resolution after ICH.
Methods
Autologous blood injection was used to construct ICH model. Mice were administered with the microglial depletion agent (PLX3397) and the specific antagonist of ADORA3, MRS1523. The neurobehavioral function was evaluated through a serious of tests. The residual hematoma volume and hemoglobin content were measured. Erythrophagocytosis was assessed using flow cytometry. Immunofluorescence, Western blot, Nissl and TUNEL staining were also performed.
Results
The expression of ADORA3 increased dynamically, and ADORA3 was mainly located in the microglia after ICH. The ADORA3 inhibitor MRS1523 could improve neurological recovery, reduce the residual hematoma volume and hemoglobin content, and promote erythrophagocytosis of microglia. In addition, the inhibition of ADORA3 reduced the expression of phagocytotic receptors AXL and MerTK, decreased the number of damaged and apoptotic neurons around hematoma on day 3 after ICH, and alleviated the neuroinflammation. In addition, PLX3397, a microglial depletion agent, impaired the protective effect of MRS1523.
Conclusion
The inhibition of ADORA3 by MRS1523 promoted phagocytosis of microglia on erythrocytes, accelerating hematoma clearance after ICH, reducing the damage of neurons and neuroinflammation around the hematoma, and ultimately promoting neurological recovery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nursing, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
- Department of Neurosurgery, Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China, 12118477@zju.edu.cn.
Zitieren
APA
Yu, Q., Yu, X., Kuang, Y., Zheng, Y., Cai, L., Zhou, J., Zhang, J., Zhu, Q., Zhou, F., Huang, H., Ding, C., Guan, G., & Fan, L. (2025). Inhibition of ADORA3 Accelerates Hematoma Resolution and Neurological Recovery after ICH. Cerebrovascular Diseases. https://doi.org/10.1159/000549241
Vancouver
Yu Q, Yu X, Kuang Y, Zheng Y, Cai L, Zhou J, et al. Inhibition of ADORA3 Accelerates Hematoma Resolution and Neurological Recovery after ICH. Cerebrovascular Diseases. 2025. doi:10.1159/000549241
BibTeX
@article{Yu2025,
author = {Yu, Qi and Yu, Xian and Kuang, Yirui and Zheng, Yonghe and Cai, Lingxin and Zhou, Jiayin and Zhang, Jiahao and Zhu, Qi and Zhou, Fengqi and Huang, Huaping and Ding, Chao and Guan, Guannan and Fan, Linfeng},
title = {Inhibition of ADORA3 Accelerates Hematoma Resolution and Neurological Recovery after ICH},
journal = {Cerebrovascular Diseases},
year = {2025},
doi = {10.1159/000549241}
}
EUVIMED